Results 241 to 250 of about 4,564,900 (257)

Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects.

Journal of Crohn's and Colitis, 2010
Yehuda Chowers, Séverine Vermeire, Matthieu Allez   +2 more
exaly  

Cell-type–restricted anti-cytokine therapy: TNF inhibition from one pathogenic source

Proceedings of the National Academy of Sciences of the United States of America, 2016
Grigory Efimov, Jürgen Scheller, Siamon Gordon   +2 more
exaly  

The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis

Best Practice and Research in Clinical Rheumatology, 2004
Marc Feldmann, Fionula M Brennan
exaly  

Risk of tuberculosis infection in anti-TNF-α biological therapy: From bench to bedside

Journal of Microbiology, Immunology and Infection, 2014
Xi Xie, Fen Li, Jin-Wei Chen
exaly  

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly.

Rheumatology, 2011
William Dixon, Kimme L. Hyrich
exaly  

Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?

Annual Review of Immunology, 2001
Marc Feldmann, Ravinder N. Maini, R N Maini   +2 more
exaly  

Anti-TNF therapy: Safety aspects of taking the risk

Autoimmunity Reviews, 2011

exaly  

Anti-TNF-α therapy improves Treg and suppresses Teff in patients with rheumatoid arthritis

Cellular Immunology, 2012
Bei Cai, Bin Yang, Zhuochun Huang
exaly  

Anti-TNF-α therapy alters the gut microbiota in proteoglycan-induced ankylosing spondylitis in mice

MicrobiologyOpen, 2019
Zhihai Su, Jincheng Huang, Qingchu Li
exaly  

Secondary syphilis occurring under anti-TNFα therapy

Joint Bone Spine, 2010
Julien Paccou
exaly